Compare Stocks

Babson Capital Global Short Duration High Yield Fund is a closed ended fixed income mutual fund launched and managed by Barings LLC. The fund is co-managed by Babson Capital Global Advisors Limited. It invests in fixed income markets across the globe. The fund primarily invests in global high-yield bonds, loans, and other income-producing instruments that are, at the time of purchase, rated below Baa3 by Moody's Investors Service, Inc. or below BBB- by Standard & Poor's Rating Services. It seeks to invest in securities with a weighted average portfolio duration of three years or less. The fund employs bottom-up fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against the Bank of America/Merrill Lynch Global Non-Financial High Yield Constrained Index. The fund was formerly known as Babson Capital Global Short Duration High Yield Fund. Babson Capital Global Short Duration High Yield Fund was formed on October 25, 2012 and is domiciled in the United States.

The Goldman Sachs Access Emerging Markets USD Bond ETF (GEMD) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund tracks a market value-weighted index of USD-denominated emerging markets government bonds of various credit quality and maturity. Bonds are selected by multiple economic factors such as governance indicators, import coverage, and inflation. GEMD was launched on Feb 15, 2022 and is managed by Goldman Sachs.

Golden Predator Mining Corp., an exploration stage company, engages in the acquisition and exploration of mineral properties in Canada. The company explores for gold, silver, copper, lead, and zinc properties. Its principal property is the Brewery Creek project covering an area of 180 square kilometers located in northwestern Yukon. The company was formerly known as Northern Tiger Resources Inc. and changed its name to Golden Predator Mining Corp. in April 2014. Golden Predator Mining Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.